Search research articles
Contact Us
Filters
Showing results (21-30 of 89) with videos related to
Page
of 9
Sort By:
Blood Cells, Molecules & Diseases
|
December 5, 2008
Fibrin architecture in clots: a quantitative polarized light microscopy analysis
Peter Whittaker, Karin Przyklenk
Circulation Research
|
August 3, 2013
Myocardial conditioning: opportunities for clinical translation
Michel Ovize, Hélène Thibault, Karin Przyklenk
American Journal of Physiology. Heart and Circulatory Physiology
|
September 27, 2005
Reduction of infarct size with D-myo-inositol trisphosphate: role of PI3-kinase and mitochondrial K(ATP) channels
Karin Przyklenk, Michelle Maynard, Peter Whittaker
American Journal of Physiology. Heart and Circulatory Physiology
|
May 30, 2006
First molecular evidence that inositol trisphosphate signaling contributes to infarct size reduction with preconditioning
Karin Przyklenk, Michelle Maynard, Peter Whittaker
Circulation Research
|
March 1, 2014
Clinical benefits of remote ischemic preconditioning: new insights...and new questions
Karin Przyklenk, Thomas H Sanderson, Maik Hüttemann
Circulation Research
|
April 2, 2016
Remote Ischemic Conditioning and the Long Road to Clinical Translation: Lessons Learned From ERICCA and RIPHeart
Kirk N Garratt, Peter Whittaker, Karin Przyklenk
Journal of Cardiovascular Pharmacology and Therapeutics
|
April 14, 2017
Parathyroid Hormone-Related Peptide: A Novel Endocrine Cardioprotective "Conditioning Mimetic"
Tanuka Datta, Karin Przyklenk, Nabanita S Datta
Journal of Cardiovascular Pharmacology and Therapeutics
|
July 23, 2013
Role of protein kinase C in ischemic "conditioning": from first evidence to current perspectives
Boris Z Simkhovich, Karin Przyklenk, Robert A Kloner
Basic Research in Cardiology
|
August 31, 2016
Inhibition of mitochondrial fission as a molecular target for cardioprotection: critical importance of the timing of treatment
Yi Dong, Vishnu V R Undyala, Karin Przyklenk
Cardiovascular Research
|
August 6, 2002
Ischemic preconditioning: a plea for rationally targeted clinical trials
Robert A Kloner, Mark T Speakman, Karin Przyklenk
Page
of 9
Search research articles
Search
Showing results (21-30 of 89) with videos related to
Sort By:
Page
of 9
Blood Cells, Molecules & Diseases
|
December 5, 2008
Fibrin architecture in clots: a quantitative polarized light microscopy analysis
Peter Whittaker, Karin Przyklenk
Circulation Research
|
August 3, 2013
Myocardial conditioning: opportunities for clinical translation
Michel Ovize, Hélène Thibault, Karin Przyklenk
American Journal of Physiology. Heart and Circulatory Physiology
|
September 27, 2005
Reduction of infarct size with D-myo-inositol trisphosphate: role of PI3-kinase and mitochondrial K(ATP) channels
Karin Przyklenk, Michelle Maynard, Peter Whittaker
American Journal of Physiology. Heart and Circulatory Physiology
|
May 30, 2006
First molecular evidence that inositol trisphosphate signaling contributes to infarct size reduction with preconditioning
Karin Przyklenk, Michelle Maynard, Peter Whittaker
Circulation Research
|
March 1, 2014
Clinical benefits of remote ischemic preconditioning: new insights...and new questions
Karin Przyklenk, Thomas H Sanderson, Maik Hüttemann
Circulation Research
|
April 2, 2016
Remote Ischemic Conditioning and the Long Road to Clinical Translation: Lessons Learned From ERICCA and RIPHeart
Kirk N Garratt, Peter Whittaker, Karin Przyklenk
Journal of Cardiovascular Pharmacology and Therapeutics
|
April 14, 2017
Parathyroid Hormone-Related Peptide: A Novel Endocrine Cardioprotective "Conditioning Mimetic"
Tanuka Datta, Karin Przyklenk, Nabanita S Datta
Journal of Cardiovascular Pharmacology and Therapeutics
|
July 23, 2013
Role of protein kinase C in ischemic "conditioning": from first evidence to current perspectives
Boris Z Simkhovich, Karin Przyklenk, Robert A Kloner
Basic Research in Cardiology
|
August 31, 2016
Inhibition of mitochondrial fission as a molecular target for cardioprotection: critical importance of the timing of treatment
Yi Dong, Vishnu V R Undyala, Karin Przyklenk
Cardiovascular Research
|
August 6, 2002
Ischemic preconditioning: a plea for rationally targeted clinical trials
Robert A Kloner, Mark T Speakman, Karin Przyklenk
Page
of 9